At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts

On Thursday, the public had the first chance to air their grievances about the FDA’s controversial Commissioner’s National Priority Voucher (CNPV) pilot program, the flagship initiative of recently departed agency leader Marty Makary, M.D.